LP3 Network Free Webinar - Veterinary Compounding, A Customized Approach

Download in electronic PDF format for $25



Search the Complete Journal Archives

Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs

Author(s):  Trissel Lawrence A, Saenz Christopher

Issue:  Jul/Aug 2002 - Compounding for BHRT and Legal and Regulatory Issues
View All Articles in Issue

Abstract:  The physical compatibility of bivalirudin (Angiomax) with 96 selected other drugs during simulated Y-site injection was evaluated by visual observation, turbidity measurement, and electronic particle content assessment (when appropriate). Five-milliliter samples of bivalirudin 5 mg/mL in 5% dextrose injection were combined with 5 mL of 96 other drugs (anti-infectives, analgesics, antihistamines, diuretics, steroids, or other supportive-care drugs that were either undiluted or diluted with either 5% dextrose injection or 0.9% sodium chloride injection [the diluent for drugs incompatible with 5% dextrose injection]). Visual examinations were performed with the unaided eye in normal, diffuse fluorescent light with a Tyndall beam (a high-intensity monodirectional light beam) to enhance the visualization of small particles and low-level turbidity. The turbidity of each sample was measured as well. The particle content of samples that did not exhibit a visible incompatibility was measured. Evaluation of the samples was performed initially and at 1 and 4 hours after preparation.

Eighty-seven of the 96 test drugs were compatible with the bivalirudin dilution during the 4-hour observation period. However, the combination of bivalirudin solution with each of nine drugs resulted in haze formation, microparticulate formation, or gross precipitation. Bivalirudin should not be administered simultaneously with those incompatible drugs.

Related Keywords: Bivalirudin, compatibility screening of during simulated Y-site administration, Bivalirudin 5 mg/mL, solutions and drugs incompatible with, Bivalirudin 5 mg/mL, solutions and drugs tested for compatibility with

Related Categories: PEER-REVIEWED, STABILITIES, COMPATIBILITIES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Compatibility Screening of Bivalirudin During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher Jul/Aug 2002 311-315 Buy
Compatibility Screening of Hextend During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Williams Kimberly Y, Baker Ma Jan/Feb 2001 69-72 Buy
Compatibility Screening of Precedex During Simulated Y-Site Administration with Other Drugs Trissel Lawrence A, Saenz Christopher, Williams Kimberly Y, Ingram Delshalonda S, Retzinger Julie P May/Jun 2002 230-233 Buy
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D May/Jun 2004 181 Buy
Compatibility of Caspofungin Acetate Injection with Other Drugs During Simulated Y-Site Coadministration Chan Pak, Heatherly Kathy, Kupiec Thomas C, Trissel Lawrence A May/Jun 2008 276-278 Buy
Compatibility of Micafungin Injection with Other Drugs During Simulated Y-Site Co-administration Trusley Craig, Kupiec Thomas C, Trissel Lawrence A May/Jun 2006 230-233 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A Mar/Apr 2008 156-160 Buy
Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A Mar/Apr 2008 170-173 Buy
Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration Trissel Lawrence A, Gilbert Doward L, Wolkin Allan C May/Jun 1999 241-244 Buy
Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel Jan/Feb 2009 78-80 Buy